The sedoheptulose kinase CARKL controls T-cell cytokine outputs and migration by promoting metabolic reprogramming
Discovery Immunology · 01.01.2024 · 3 (1)
DOI: 10.1093/discim/kyae016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Discovery Immunology, online erschienen am 19.11.2024. Verfasst von Michelangelo Certo und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine and Health, University of Birmingham, Birmingham, GB, UK. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation Senior Research Fellowship, Diabetes UK.
Abstract (Originalsprache)
Background
Immunometabolism is a crucial determinant of immune cell function, influencing cellular activation and differentiation through metabolic pathways. The intricate interplay between metabolism and immune responses is highlighted by the distinct metabolic programs utilized by immune cells to support their functions. Of particular interest is the pentose phosphate pathway (PPP), a key metabolic pathway branching out of glycolysis that plays a pivotal role in generating NADPH and pentose sugars crucial for antioxidant defense and biosynthesis. The sedoheptulose kinase Carbohydrate Kinase-like protein (CARKL), an enzyme involved in the PPP, emerges as a critical regulator of cell metabolism and was previously shown to play a role in macrophage function.
Methods
This study delves into the impact of CARKL expression on T-cell functionality, revealing dynamic alterations in response to cellular activation. Notably, CARKL overexpression leads to significant metabolic shifts in T cells, affecting mitochondrial respiration, ATP production, and inflammatory cytokine profiles. Furthermore, CARKL modulation influences T-cell motility by regulating chemokine receptor expression, particularly compromising CXCR3 expression and impairing T-cell migration in response to specific chemokine signals.
Conclusions
These findings underscore the multifaceted role of CARKL as a metabolic regulator shaping T-cell responses. Overall, our data reveal the complex regulatory mechanisms orchestrated by CARKL in T-cell function, with implications for immune regulation. Further exploration of the molecular interactions between CARKL and metabolic reprogramming in T cells could provide valuable insights into immune regulation and potential therapeutic strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Medicine and Health, University of Birmingham, Birmingham, GB, UK.
- William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, GB, UK.
ORCID-Profile: Michelangelo Certo, Joanne Smith, Claudio Mauro
Förderung
- British Heart Foundation Senior Research Fellowship
- Diabetes UK
Zitieren
APA
Certo, M., Niven, J., Haas, R., Rudzinska, P., Smith, J., Cucchi, D., Hombrebueno, J. R., & Mauro, C. (2024). The sedoheptulose kinase CARKL controls T-cell cytokine outputs and migration by promoting metabolic reprogramming. Discovery Immunology, 3(1). https://doi.org/10.1093/discim/kyae016
Vancouver
Certo M, Niven J, Haas R, Rudzinska P, Smith J, Cucchi D, et al. The sedoheptulose kinase CARKL controls T-cell cytokine outputs and migration by promoting metabolic reprogramming. Discovery Immunology. 2024;3(1). doi:10.1093/discim/kyae016
BibTeX
@article{Certo2024,
author = {Certo, Michelangelo and Niven, Jennifer and Haas, Robert and Rudzinska, Paula and Smith, Joanne and Cucchi, Danilo and Hombrebueno, Jose R and Mauro, Claudio},
title = {The sedoheptulose kinase CARKL controls T-cell cytokine outputs and migration by promoting metabolic reprogramming},
journal = {Discovery Immunology},
year = {2024},
volume = {3},
number = {1},
doi = {10.1093/discim/kyae016}
}
EUVIMED